IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $640,000 | +49.9% | 13,786 | +6.5% | 0.00% | +50.0% |
| Q3 2020 | $427,000 | +52.0% | 12,946 | +26.3% | 0.00% | 0.0% |
| Q2 2020 | $281,000 | -4.4% | 10,249 | +4.3% | 0.00% | 0.0% |
| Q1 2020 | $294,000 | -3.3% | 9,829 | -10.6% | 0.00% | +100.0% |
| Q4 2019 | $304,000 | +52.0% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $200,000 | -25.9% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $270,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |